ADAM9 as a Potential Target Molecule in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|20|2282-2287

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.20, 2009-07, pp. : 2282-2287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 2, 2015-06 ,pp. : 97-104

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM Proteins- Therapeutic Potential in Cancer

By  

Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. : 720-732

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM10 as a Therapeutic Target for Cancer and Inflammation

By  

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2288-2299

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM10 as a Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 1, 2008-02 ,pp. : 2-8

Bentham Science Publishers

Access to resources Recommend Favorite

Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor

By  

Current Cancer Drug Targets, Vol. 13, Iss. 6, 2013-07 ,pp. : 686-697

Bentham Science Publishers

Access to resources Recommend Favorite